Primary Care POC Diagnostics Market Analysis

Primary Care POC Diagnostics Market Analysis

To get key market trends

  Download Free Sample

The primary care POC diagnostics market by product is categorized into glucose monitoring, cardiometabolic testing products, infectious disease testing products, coagulation testing products, pregnancy and fertility testing products, tumor/cancer marker testing products, urinalysis testing products, cholesterol testing products, hematology testing products, drug-of-abuse (DoA) testing products, fecal occult testing products, and other products. The glucose monitoring segment garnered USD 4.5 billion revenue size in the year 2023.

• High segment growth is attributed to the increasing adoption of portable, highly convenient, and cost-effective as well as rapid primary POC glucose tests. Furthermore, the advantage of point of care testing for blood glucose (BG) is its rapid turn-around time as compared to central laboratory testing (CLT). For instance, the turn-around time for blood glucose point of care testing (POCT) is 5 minutes while that of CLT is between 30-60 minutes.

   

• Moreover, the postanalytical and preanalytical factors such as transportation, multiple user handling, order verification and delayed reporting can affect the analysis of test. Thus, aforementioned factors are eliminated in the primary care blood glucose POCT, thereby supplementing the market demand.

Based on end-use, the primary care POC diagnostics market is segmented into hospitals, diagnostic centers, research laboratories, home care settings, and other end-users. The hospitals segment garnered USD 6.5 billion revenue size in the year 2023.

• Hospitals have primary care POC diagnostics teams and specialized primary care POC diagnostics nurses that are experienced in assessing, treating, and managing various types of diseases. They are knowledgeable about the latest primary care POC diagnostics techniques and technologies.

   

• Further, due to high incidence and prevalence of chronic diseases, there is a huge surge in number of patients getting hospitalized. The POC tests are much convenient for constant monitoring of specific analyte or repeated/ routine follow-up tests for tracking the treatment progress.

   

• Moreover, the primary care point of care tests reduces turnaround time drastically, which is essential and very effective in managing complicated cases in particular cardiovascular disease. The use of primary care POCT systems uplift the status of healthcare in hospitals, thereby fostering the industry landscape.

U.S. primary care POC diagnostics market accounted for USD 6.9 billion revenue size in 2023 and is predicted to witness substantial market growth over the analysis timeline.

• Increasing government initiatives towards chronic and infectious diseases will accelerate industry expansion.

   

• For instance, National Diabetes Education Program (NDEP) is the joint effort of the National Institutes of Health and Centers for Disease Control and Prevention (CDC). National Diabetes Education Program seeks at reducing burden of prediabetes by delivering diabetes-related education to a range of people of emerging nations, faith-based organizations, ethnic minorities, community-based organizations, and healthcare providers.

   

• Furthermore, the strong focus on research and development and continuous innovation in primary care POC diagnostics will bolster the market demand.